Incidence and long-term cost of steroid-related side effects after renal transplantation (Q33600126)

28 July 2017

title

Incidence and long-term cost of steroid-related side effects after renal transplantation (English)

1 reference

28 July 2017

Veenstra DL

1

1 reference

28 July 2017

Best JH

2

1 reference

28 July 2017

Hornberger J

3

1 reference

28 July 2017

Sullivan SD

4

1 reference

28 July 2017

Hricik DE

5

1 reference

28 July 2017

publication date

1 May 1999

1 reference

American Journal of Kidney Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

33

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

829-839

1 reference

Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Prevention of transplant rejection: current treatment guidelines and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Secular trends in stroke incidence and mortality. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

The content and cost of cataract surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

A controlled trial of steroids in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Rapid loss of vertebral mineral density after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Avascular necrosis of bone after cardiac transplantation. Prevalence and relationship to administration and dosage of steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Effect of time elapsed since transplantation on lipid and lipoprotein abnormalities in renal transplant patients: role of maintenance prednisone and gender influence.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970414-2

7 January 2021

10.1016/S0272-6386(99)70414-2

Identifiers

DOI

1 reference

28 July 2017

1 reference